Capital Fund Management (CFM)
IBB icon

Capital Fund Management (CFM)’s iShares Biotechnology ETF IBB Stock Holding History

Capital Fund Management (CFM)’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.47M Sell
14,600
-43,800
-75% -$7.49M 0.01% 1257
2025
Q4 		$9.86M Sell
58,400
-68,400
-54% -$11.1M 0.03% 842
2025
Q3 		$18.3M Buy
126,800
+50,900
+67% +$6.95M 0.05% 552
2025
Q2 		$9.6M Buy
75,900
+39,300
+107% +$4.82M 0.03% 770
2025
Q1 		$4.68M Buy
36,600
+3,500
+11% +$475K 0.01% 1034
2024
Q4 		$4.38M Buy
33,100
+5,200
+19% +$731K 0.01% 1144
2024
Q3 		$4.06M Sell
27,900
-46,200
-62% -$6.68M 0.01% 1118
2024
Q2 		$10.2M Buy
74,100
+5,000
+7% +$667K 0.03% 662
2024
Q1 		$9.48M Sell
69,100
-1,800
-3% -$246K 0.03% 755
2023
Q4 		$9.63M Buy
+70,900
New +$8.65M 0.03% 801
2023
Q2 		– Sell
-55,400
Closed -$7.16M – 1770
2023
Q1 		$7.16M Buy
+55,400
New +$7.25M 0.03% 605
2022
Q4 		– Sell
-12,200
Closed -$1.43M – 1483
2022
Q3 		$1.43M Sell
12,200
-19,300
-61% -$2.4M 0.01% 965
2022
Q2 		$3.71M Sell
31,500
-3,100
-9% -$368K 0.03% 604
2022
Q1 		$4.51M Buy
+34,600
New +$4.51M 0.04% 609
2021
Q2 		– Sell
-11,500
Closed -$1.73M – 1528
2021
Q1 		$1.73M Sell
11,500
-9,500
-45% -$1.51M 0.02% 790
2020
Q4 		$3.18M Sell
21,000
-154,600
-88% -$22.1M 0.03% 620
2020
Q3 		$23.8M Buy
175,600
+114,800
+189% +$15.6M 0.29% 95
2020
Q2 		$8.31M Buy
60,800
+45,700
+303% +$5.83M 0.13% 218
2020
Q1 		$1.63M Buy
+15,100
New +$1.74M 0.03% 588
2019
Q2 		– Sell
-4,800
Closed -$537K – 1752
2019
Q1 		$537K Sell
4,800
-6,900
-59% -$757K ﹤0.01% 1225
2018
Q4 		$1.13M Sell
11,700
-12,100
-51% -$1.28M 0.01% 1065
2018
Q3 		$2.9M Buy
23,800
+7,700
+48% +$907K 0.02% 967
2018
Q2 		$1.77M Buy
+16,100
New +$1.72M 0.01% 1129
2018
Q1 		– Sell
-40,600
Closed -$4.33M – 1985
2017
Q4 		$4.33M Sell
40,600
-52,400
-56% -$5.6M 0.02% 720
2017
Q3 		$10.3M Buy
+93,000
New +$9.94M 0.07% 325
2017
Q1 		– Sell
-53,400
Closed -$4.72M – 1625
2016
Q4 		$4.72M Sell
53,400
-43,500
-45% -$3.96M 0.04% 514
2016
Q3 		$9.35M Sell
96,900
-558,000
-85% -$53.1M 0.09% 287
2016
Q2 		$56.2M Buy
654,900
+140,700
+27% +$12.6M 0.53% 29
2016
Q1 		$44.7M Buy
514,200
+332,700
+183% +$29.8M 0.43% 53
2015
Q4 		$20.5M Sell
181,500
-2,100
-1% -$228K 0.21% 128
2015
Q3 		$18.6M Buy
183,600
+82,200
+81% +$9.86M 0.21% 125
2015
Q2 		$12.5M Buy
101,400
+71,400
+238% +$8.55M 0.16% 177
2015
Q1 		$3.43M Sell
30,000
-22,200
-43% -$2.45M 0.05% 441
2014
Q4 		$5.28M Sell
52,200
-25,500
-33% -$2.48M 0.06% 427
2014
Q3 		$7.09M Buy
+77,700
New +$6.82M 0.08% 316

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Capital Fund Management (CFM)'s IBB Position: Q1 2026 in Review

Capital Fund Management (CFM) reduced its iShares Biotechnology ETF (IBB) stake by 39% in Q1 2026, selling an estimated $9M and leaving 81,298 shares worth $13.7M. The position accounts for 0.06% of the portfolio, ranked #431.

Capital Fund Management (CFM) first reported a position in IBB in Q3 2014 and has held it in 23 quarters since. The position peaked at $22.6M in Q4 2025. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • Capital Fund Management (CFM) held 81,298 shares of iShares Biotechnology ETF worth $13.7M as of Q1 2026.
  • Capital Fund Management (CFM) sold 52,603 iShares Biotechnology ETF shares in Q1 2026, an estimated $9M.
  • iShares Biotechnology ETF made up 0.06% of Capital Fund Management (CFM)'s portfolio in Q1 2026, its #431 holding.
  • Capital Fund Management (CFM) first reported a position in iShares Biotechnology ETF in Q3 2014 and has held it in 23 quarters since.
  • Capital Fund Management (CFM)'s iShares Biotechnology ETF position peaked at $22.6M in Q4 2025.
  • 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Capital Fund Management (CFM)'s 13F filing for Q1 2026, filed 14 May 2026.